A8F-32332-08959
2 vaccinations
1 coded response
1 check-in
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 757 / TX
- Registered
- 2021-01-19
- Relationship
- Self
Timeline
-
2020-12-29
Dose 1 — Pfizer-BioNTech
-
2021-01-19
Registered in v-safe
-
2021-01-19
Dose 2 — Pfizer-BioNTech
-
2021-02-09
Survey response — 21 day, dose 2MedDRA: Abortion spontaneous, Uterine dilation and curettage — Feeling: Poor · Be unable to work, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-02-09
Report sent to call center — 21 day, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | |
| 2 | 2021-01-19 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-09 | Unsuccessful |
Free text
Release 3
Symptoms: Miscarriage. 9 weeks 3 daysBaby measured 6 weeks 4 days
Healthcare visit (other): D&C
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Uterine dilation and curettage | ✓ | ✓ | ✓ |
| SD | Abortion spontaneous | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release